This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n5http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n12http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168915/price-of-originator/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168915/reimbursement/
skoshttp://www.w3.org/2004/02/skos/core#
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168915/
n15http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168915/core-reimbursement/
n7http://linked.opendata.cz/resource/sukl/indgroup/
n20http://linked.opendata.cz/resource/sukl/packing/
n17http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/002352/
n14http://linked.opendata.cz/resource/sukl/company/
n18http://linked.opendata.cz/resource/sukl/active-ingredient/
n11http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168915/price/
n13http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n16http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/sukl/df/
n4http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0168915
rdf:type
n3:MedicinalProductPackaging
dcterms:title
EFAVIRENZ TEVA 600 MG
skos:notation
0168915
n3:hasATCCode
n4:J05AG03
n3:hasActiveIngredient
n18:EFAVIRENZUM
n3:hasDefinedDailyDose
n10:ddd
n3:hasDosageForm
n6:TBL-FLM-POR
n3:hasPackagingSize
30 II
n3:hasPacking
n20:BLI
n3:hasRegistrationHolder
n14:TEVNL
n3:hasRegistrationState
n16:R
n3:hasRouteOfAdministration
n5:POR
n3:hasStrength
600MG
n3:hasIndicationGroup
n7:42
n3:hasSpecializationRestriction
n13:blank-cell
n3:containsDefinedDailyDoses
30.0
n3:hasRegistrationCode
EU/1/11/742/007
n3:hasTitleSupplement
POR TBL FLM 30X600MG
n3:containsUsualTherapeuticalDailyDoses
30
n3:hasCoreReimbursementSpecification
n15:2015-06-01 n15:2015-07-01 n15:2015-04-02 n15:2015-05-01 n15:2015-03-01 n15:2015-04-01 n15:2015-02-01 n15:2015-07-02
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n12:2015-03-01 n12:2015-04-01 n12:2015-02-01 n12:2015-06-01 n12:2015-07-01 n12:2015-04-02 n12:2015-05-01 n12:2015-07-02
n3:hasPriceSpecification
n11:2015-07-02 n11:2015-04-02 n11:2015-05-01 n11:2015-06-01 n11:2015-07-01 n11:2015-02-01 n11:2015-03-01 n11:2015-04-01
n3:hasReimbursementSpecification
n9:2015-06-01 n9:2015-07-01 n9:2015-04-02 n9:2015-05-01 n9:2015-03-01 n9:2015-04-01 n9:2015-02-01 n9:2015-07-02
n3:hasUsualTherapeuticalDailyDose
n10:utdd
n3:spcFile
http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F002352%2FWC500121447.pdf
n3:spcUri
n17:WC500121447.pdf